Legacy Pharmaceutical Packaging said it is voluntarily recalling 43 lots of drugs used to treat congestive heart failure and high blood pressure, according to a news release from the U.S. Food and Drug Administration (FDA) on March 15.
The firm is recalling Losartan potassium tablets after two other pharmaceutical companies, Camber Pharmaceuticals and Torrent Pharmaceuticals, recalled medications after they found trace amounts of NBMA. The tablets were manufactured by Hetero Labs.
